Cargando…

Novel Calcium-Binding Ablating Mutations Induce Constitutive RET Activity and Drive Tumorigenesis

Distinguishing oncogenic mutations from variants of unknown significance (VUS) is critical for precision cancer medicine. Here, computational modeling of 71,756 RET variants for positive selection together with functional assays of 110 representative variants identified a three-dimensional cluster o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tabata, Junya, Nakaoku, Takashi, Araki, Mitsugu, Yoshino, Ryunosuke, Kohsaka, Shinji, Otsuka, Ayaka, Ikegami, Masachika, Ui, Ayako, Kanno, Shin-ichiro, Miyoshi, Keiko, Matsumoto, Shigeyuki, Sagae, Yukari, Yasui, Akira, Sekijima, Masakazu, Mano, Hiroyuki, Okuno, Yasushi, Okamoto, Aikou, Kohno, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2022
Materias:	Molecular Cell Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574375/ https://www.ncbi.nlm.nih.gov/pubmed/36166639 http://dx.doi.org/10.1158/0008-5472.CAN-22-0834

Ejemplares similares

A secondary RET mutation in the activation loop conferring resistance to vandetanib
por: Nakaoku, Takashi, et al.
Publicado: (2018)

Exploring ligand binding pathways on proteins using hypersound-accelerated molecular dynamics
por: Araki, Mitsugu, et al.
Publicado: (2021)

Hydrophobic interactions at subsite S1′ of human dipeptidyl peptidase IV contribute significantly to the inhibitory effect of tripeptides
por: Araki, Mitsugu, et al.
Publicado: (2020)

Integrated approach to functional analysis of an ERBB2 variant of unknown significance detected by a cancer gene panel test
por: Harada, Yohei, et al.
Publicado: (2022)

Expression of ret Proto‐oncogene in Human Neuroblastomas
por: Nagao, Minako, et al.
Publicado: (1990)

Identification of key interactions between SARS-CoV-2 main protease and inhibitor drug candidates
por: Yoshino, Ryunosuke, et al.
Publicado: (2020)

Molecular Dynamics Simulation reveals the mechanism by which the Influenza Cap-dependent Endonuclease acquires resistance against Baloxavir marboxil
por: Yoshino, Ryunosuke, et al.
Publicado: (2019)

An 83‐year‐old patient with RET fusion‐positive non‐small cell lung cancer experiencing severe hepatic disorder due to selpercatinib administration
por: Nakashima, Kazuhisa, et al.
Publicado: (2023)

Emergence and Targeting of Acquired and Hereditary Resistance to Multikinase RET Inhibition in Patients With RET-Altered Cancer
por: Wirth, Lori J., et al.
Publicado: (2019)

Improvement in predicting drug sensitivity changes associated with protein mutations using a molecular dynamics based alchemical mutation method
por: Ono, Fumie, et al.
Publicado: (2020)

Preclinical assessment of combination therapy of EGFR tyrosine kinase inhibitors in a highly heterogeneous tumor model
por: Ikeuchi, Hiroshi, et al.
Publicado: (2022)

Calculation of absolute binding free energies between the hERG channel and structurally diverse drugs
por: Negami, Tatsuki, et al.
Publicado: (2019)

Extensive analysis of 59 sarcoma‐related fusion genes identified pazopanib as a potential inhibitor to COL1A1‐PDGFB fusion gene
por: Hirose, Takeshi, et al.
Publicado: (2023)

Precision therapy for RET-altered cancers with RET inhibitors
por: Thein, Kyaw Z., et al.
Publicado: (2021)

RET kinase inhibitors for RET-altered thyroid cancers
por: Vodopivec, Danica M., et al.
Publicado: (2022)

RET signaling pathway and RET inhibitors in human cancer
por: Regua, Angelina T., et al.
Publicado: (2022)

RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven Malignancies
por: Solomon, Benjamin J., et al.
Publicado: (2020)

RET inhibition in novel patient-derived models of RET fusion- positive lung adenocarcinoma reveals a role for MYC upregulation
por: Hayashi, Takuo, et al.
Publicado: (2021)

Ret-dependent and Ret-independent mechanisms of Gfl-induced sensitization
por: Schmutzler, Brian S, et al.
Publicado: (2011)

Selective RET kinase inhibition for patients with RET-altered cancers
por: Subbiah, V, et al.
Publicado: (2018)

Machine learning accelerates MD-based binding pose prediction between ligands and proteins
por: Terayama, Kei, et al.
Publicado: (2018)

Current State of Gastric Stump Carcinoma in Japan: Based on the Results of a Nationwide Survey
por: Tanigawa, Nobuhiko, et al.
Publicado: (2010)

Hallmarks of RET and Co-occuring Genomic Alterations in RET-aberrant Cancers
por: Adashek, Jacob J., et al.
Publicado: (2021)

The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers
por: Rosen, Ezra Y., et al.
Publicado: (2022)

Precision oncology with selective RET inhibitor selpercatinib in RET-rearranged cancers
por: Gouda, Mohamed A., et al.
Publicado: (2023)

Phase 1/2 study of alectinib in RET-rearranged previously-treated non-small cell lung cancer (ALL-RET)
por: Takeuchi, Shinji, et al.
Publicado: (2021)

Treatment Strategies for ARID1A-Deficient Ovarian Clear Cell Carcinoma
por: Takahashi, Kazuaki, et al.
Publicado: (2021)

Mutual induced-fit mechanism drives binding between intrinsically disordered Bim and cryptic binding site of Bcl-xL
por: Bekker, Gert-Jan, et al.
Publicado: (2023)

RET-rearranged non-small-cell lung carcinoma: a clinicopathological and molecular analysis
por: Tsuta, K, et al.
Publicado: (2014)

C-CAT: The National Datacenter for Cancer Genomic Medicine in Japan
por: Kohno, Takashi, et al.
Publicado: (2022)

Involvement of RET oncogene in human tumours: specificity of RET activation to thyroid tumours.
por: Santoro, M., et al.
Publicado: (1993)

Response to RET-Specific Therapy in RET Fusion-Positive Anaplastic Thyroid Carcinoma
por: Dias-Santagata, Dora, et al.
Publicado: (2020)

The RET gene encodes RET protein, which triggers intracellular signaling pathways for enteric neurogenesis, and RET mutation results in Hirschsprung's disease
por: Bhattarai, Chacchu, et al.
Publicado: (2022)

Androgen receptor mRNA expression is a predictor for recurrence-free survival in non-muscle invasive bladder cancer
por: Yasui, Masato, et al.
Publicado: (2019)

Expression of C-terminal ALK, RET, or ROS1 in lung cancer cells with or without fusion
por: Furugaki, Koh, et al.
Publicado: (2019)

CompRet: a comprehensive recommendation framework for chemical synthesis planning with algorithmic enumeration
por: Shibukawa, Ryosuke, et al.
Publicado: (2020)

Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma
por: Tabata, Chiharu, et al.
Publicado: (2013)

miRNA Profiling Reveals Dysregulation of RET and RET-Regulating Pathways in Hirschsprung's Disease
por: Li, Shuangshuang, et al.
Publicado: (2016)

EGF Induced RET Inhibitor Resistance in CCDC6-RET Lung Cancer Cells
por: Chang, Hyun, et al.
Publicado: (2017)

Aggravated pulmonary injury after subarachnoid hemorrhage in PDGF-B(ret/ret) mice
por: Pan, Pengyu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f6klscmnbikm3gfpc7tmqfqjok